• QPRT Drives Breast Cancer Invasion via P2Y11-Mediated Signal

  2026-05-12

  This study reveals that quinolinate phosphoribosyltransferase (QPRT) upregulation enhances breast cancer invasiveness through myosin light chain phosphorylation, implicating purinergic P2Y11 receptor signaling as a mechanistic link. Inhibiting P2Y11 reverses these effects, highlighting new experimental strategies for dissecting metastatic pathways in oncology research.

• Cationic Lipid Composition Tunes mRNA Lipoplex Immunogenicit

  2026-05-12

  This study systematically evaluates how different cationic and neutral lipid combinations in lipoplex formulations influence antibody production and transgene expression following systemic mRNA delivery in mice. The findings underscore the importance of lipid selection for optimizing vaccine efficacy and provide actionable insights for mRNA delivery system design.

• Reliable Cell Proliferation Assays with Cell Counting Kit-8

  2026-05-11

  This article addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity measurement, demonstrating how the Cell Counting Kit-8 (CCK-8) (SKU K1018) delivers reproducible, sensitive, and user-friendly results. Drawing on practical scenarios, protocol optimization, and vendor selection criteria, it provides actionable guidance for biomedical researchers seeking robust data with CCK-8.

• Triacetin in Experimental Metabolism: Protocols and Troubles

  2026-05-11

  Triacetin (glyceryl triacetate) is redefining metabolic and oncology research through its dual roles as a substrate and signaling molecule. This guide translates cutting-edge evidence into stepwise protocols, advanced use-cases, and practical troubleshooting, making Triacetin from APExBIO a preferred reagent in high-impact laboratory workflows.

• Perifosine (KRX-0401): Advanced Workflows in Apoptosis and R

  2026-05-10

  Perifosine (KRX-0401) is a synthetic alkylphospholipid Akt inhibitor uniquely positioned for both apoptosis assays and radiation sensitization studies in cancer research. This guide translates cutting-edge findings and validated protocols into actionable, troubleshooting-rich workflows, spotlighting APExBIO’s Perifosine as a benchmark tool for Akt/mTOR pathway interrogation.

• Annexin V-FITC/PI Apoptosis Assay Kit: Enhanced Decision-Mak

  2026-05-09

  Explore how the Annexin V-FITC/PI Apoptosis Assay Kit enables precise, evidence-driven differentiation of apoptotic stages in cancer research. This article uniquely connects advanced assay design with translational choices in oncology, integrating new reference findings and practical protocol guidance.

• AMPK Modulation Mitigates Airway Inflammation in Obesity-Lin

  2026-05-09

  This study elucidates how AMPK activation suppresses M1 macrophage polarization via the JAK2/STAT3 pathway, thereby attenuating airway inflammation in obesity-related asthma. The findings highlight a mechanistic link between metabolic signaling and immune cell behavior, informing new directions for targeted intervention in refractory asthma phenotypes.

• Nocodazole: Precision Microtubule Polymerization Inhibitor W

  2026-05-08

  Nocodazole from APExBIO empowers researchers to precisely manipulate microtubule dynamics for cell cycle, trafficking, and cancer research workflows. This article provides actionable protocols, troubleshooting strategies, and highlights new frontiers inspired by α-tubulin lactylation to optimize your experimental outcomes.

• Tigecycline: Glycylcycline Antibiotic for Multidrug-Resistan

  2026-05-07

  Tigecycline is a first-in-class glycylcycline antibiotic with proven efficacy against multidrug-resistant bacteria. It acts as a 30S ribosomal subunit inhibitor, demonstrating high potency in both in vitro and in vivo models. This article details its mechanism, evidence base, and protocol parameters for research applications.

• O-GlcNAcylation Links Wnt Signaling to Osteoblast Metabolism

  2026-05-07

  This study uncovers how O-GlcNAcylation mediates Wnt3a-driven bone formation by modulating glycolysis in osteoblasts. Through genetic and biochemical approaches, the authors show that O-GlcNAcylation of PDK1 is essential for Wnt-induced bone anabolism, highlighting a new metabolic control point in osteogenesis.

• Applied Cancer Research with MCL-1 Inhibitor A-1210477

  2026-05-06

  A-1210477, a highly selective MCL-1 inhibitor, offers precision control of apoptosis in MCL-1-dependent cancer cell models. This guide translates foundational research into actionable workflows—highlighting assay setup, troubleshooting, and data-driven optimization for advanced cancer research.

• Q-VD-OPh in Apoptosis and Lysoptosis: Precision Tools for Ce

  2026-05-06

  Explore how Q-VD-OPh, a potent pan-caspase inhibitor, enables precise dissection of apoptotic and lysosome-dependent cell death pathways. This article delivers new scientific insights for apoptosis research and practical guidance for protocol optimization.

• Molidustat (BAY85-3934): Optimizing HIF-PH Inhibition Workfl

  2026-05-05

  Molidustat (BAY85-3934) enables precise, reproducible control of hypoxia signaling and erythropoietin stimulation in both in vitro and in vivo models. Its unique selectivity and solubility empower researchers to address chronic kidney disease anemia and beyond with unprecedented workflow flexibility.

• Plk1 Regulates p31comet in Mitotic Checkpoint Complex Disass

  2026-05-05

  This study uncovers how Polo-like kinase 1 (Plk1) directly regulates p31comet activity in the disassembly of mitotic checkpoint complexes (MCC), a critical process ensuring accurate chromosome segregation in mitosis. By mapping Plk1-dependent phosphorylation of p31comet, the research delineates a key regulatory mechanism that prevents futile cycles of MCC assembly and disassembly, with implications for understanding spindle assembly checkpoint dynamics and potential mitotic progression inhibitors.

• Apicidin: Translating Epigenetic Disruption into Research Im

  2026-05-04

  Apicidin, a selective histone deacetylase inhibitor, is redefining the boundaries between cancer epigenetics and reproductive toxicology. This thought-leadership article integrates recent mechanistic insights—including disruptive effects on oocyte maturation—with strategic guidance for translational researchers. We bridge evidence from oncology, toxicology, and advanced cell biology, offering protocol parameters and outlooks for responsible innovation.

11607 records 1/774 page Next 12345 下5页 Last page